Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269501
Max Phase: Preclinical
Molecular Formula: C20H15N5OS
Molecular Weight: 373.44
Associated Items:
ID: ALA5269501
Max Phase: Preclinical
Molecular Formula: C20H15N5OS
Molecular Weight: 373.44
Associated Items:
Canonical SMILES: O=C1CS/C(=N\c2cc(-c3c[nH]c4ccccc34)nn2-c2ccccc2)N1
Standard InChI: InChI=1S/C20H15N5OS/c26-19-12-27-20(23-19)22-18-10-17(24-25(18)13-6-2-1-3-7-13)15-11-21-16-9-5-4-8-14(15)16/h1-11,21H,12H2,(H,22,23,26)
Standard InChI Key: NTGIZUSJRIPDJL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 373.44 | Molecular Weight (Monoisotopic): 373.0997 | AlogP: 3.87 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.57 | CX Basic pKa: 1.10 | CX LogP: 4.09 | CX LogD: 3.87 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.57 | Np Likeness Score: -0.98 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):